N/A
N=72
Prevention of Alcohol-related Sexual Revictimization in College
Sexual Assault
Bottom Line
View on ClinicalTrials.gov: NCT05257603 ↗Enrolled (actual)
72
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Days Per Month Hazardous Drinking — 7.54; 10.40; 1.97; 1.53 Days per Month Hazardous Drinking — p=<0.99
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- RPCW (Behavioral); HEC (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- State University of New York at Buffalo
- Primary completion
- Nov 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Days Per Month Hazardous Drinking |
7.54; 10.40; 1.97; 1.53; 3.72; 3.52 | <0.99 |
| PRIMARY Severe Sexual Assault (Revictimization) |
5; 7; 32; 28 | <.29 |
| PRIMARY Mean Number of Key Presses When Watching Risk Video |
6.58; 6.64 | <0.99 |
| PRIMARY Latency to Choose to Leave a Videotaped Scenario (Seconds) |
-21.17; -6.34 | <0.45 |
| SECONDARY Difficulties in Emotion Regulation Scale |
92.44; 87.39; 82.89; 83.61; 81.33; 82.72 | <.10 |
| SECONDARY State Difficulties in Emotion Regulation Scale |
38.57; 38.71; 35.79; 38.04 | <.10 |
| SECONDARY The Protective Behavioral Strategies Scale |
58.23; 55.21; 61.08; 60.00; 61.92; 62.58 | <.10 |
| SECONDARY The Dating Self-Protection Against Rape Scale |
50.15; 55.61; 46.23; 52.67; 49.65; 49.39 | <.098 |
Summary
This pilot randomized controlled trial (RCT) is designed to test a new intervention designed to reduce college women's risk for sexual revictimization (SRV). The intervention targets women with a history of sexual assault (SA) and recent hazardous drinking (HD), as these women are at highest risk for SRV. The primary goals of the intervention are to decrease women's HD, improve their ability to perceive cues that signal risk for SRV, and strengthen their behavioral skills in situations associated with an increased risk for SRV. The intervention, Revictimization Prevention for College Women (RPCW) is a multi-modal intervention that includes two on-line interactive education modules and two in-person group skills-based training sessions that focus on problem solving training and behavioral rehearsal. The pilot RCT of the RPCW intervention will include 96 college women with follow-up assessments at 3- and 6-months post intervention. Women will be randomly assigned to either the RPCW intervention or to a Health Education Control (HEC) condition. The pilot RCT will be used to establish the feasibility of recruitment, the acceptability and safety of the RPCW intervention, and provide initial efficacy data that will assist in power calculations for a Stage II efficacy trial. The investigators hypothesize that women in RPCW intervention will report fewer days of hazardous drinking and improved perception of sexual assault risk cues compared with participants in the HEC condition. In addition, women in the RPCW intervention will report increased knowledge of safe dating practices and protective behavioral (drinking) strategies compared with participants in the HEC condition. Finally, women in the RPCW intervention will report lower rates of SRV as compared with participants in the HEC condition at the 6-month post-intervention follow-up.
Eligibility Criteria
Inclusion Criteria
- 18-22 years of age
- Current first- or second-year female student at the college
- Able to comprehend the study protocol, consent form and provide written consent
- Had a prior SA experienced since the age of 14 years (i.e., adolescent or young adult)
- Engaged in hazardous drinking in the past month (i.e., ≥ 4 drinks 1 or more times in past 30 days).
Exclusion Criteria
- Major mental illness as indicated by: (a) severe level of depressive symptoms as assessed by the Beck Depression Inventory-II or a self-reported diagnosis of: (b) Schizophrenia, (c) Bipolar Disorder
- Report experiencing homicidal or suicidal ideation
- Unable to commit to attending 2 weekly in-person group sessions
- No access to a computer to complete the on-line intervention modules.
Data sourced from ClinicalTrials.gov (NCT05257603). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.